Ascend Capital’s Aceragen Inc ACGN Stock Holding History

Ascend Capital’s Portfolio ACGN Stock Details ACGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-1,837	Closed	-$925K	–	178
2015 Q2	$925K	Buy	+1,837	New	+$843K	0.03%	135

Other funds holding ACGN

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Natixis Paris, France $28B AUM 26.79% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Ascend Capital's ACGN Position: Q3 2015 in Review

Ascend Capital sold out of Aceragen Inc (ACGN) in Q3 2015, closing a stake of 1,837 shares — an estimated $925K sold.

Ascend Capital first reported a position in ACGN in Q2 2015 and held it in 1 quarter. The position peaked at $925K in Q2 2015. 84 funds tracked by Wall St. Rank hold ACGN as of Q3 2015.

Ascend Capital reported no remaining Aceragen Inc position as of Q3 2015 after selling out during the quarter.
Ascend Capital sold 1,837 Aceragen Inc shares in Q3 2015, an estimated $925K.
Ascend Capital first reported a position in Aceragen Inc in Q2 2015 and held it in 1 quarter.
Ascend Capital's Aceragen Inc position peaked at $925K in Q2 2015.
84 funds tracked by Wall St. Rank held Aceragen Inc as of Q3 2015.

Based on Ascend Capital's 13F filing for Q3 2015, filed 13 Nov 2015.